Contribution: Industrial Research Assistance Program – Contributions to Firms
Influx Inc. (ON)
-$38,086.00
Development of Structured Reports for Healthcare
EF 2017-18 · 2017-11-26
Résumé
Influx will be developing five new structured reports which will enable Influx to offer these solutions to hospital departments that we have not targeted in the past, namely Cardiac CT and Pediatrics. Also, our existing (“old”) eight structured reports will be tested and verified with a new PACS system._x000D_
_x000D_
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Scarborough|Scarborough, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
840077309
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
The end date of this agreement has been modified by -153 days.
Additional Information (French)
La date de fin du présent accord a été changé (-153 jours)
Agreement End Date
2018-04-30
Agreement Number
895974
Agreement Start Date
2017-11-26
Agreement Title
Development of Structured Reports for Healthcare
Agreement Title (French)
Développement de rapports structurés pour les soins de santé
Agreement Type
Contribution
Agreement Value
-$38,086.00
Amendment Date
2018-06-07
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Influx will be developing five new structured reports which will enable Influx to offer these solutions to hospital departments that we have not targeted in the past, namely Cardiac CT and Pediatrics. Also, our existing (“old”) eight structured reports will be tested and verified with a new PACS system._x000D_
_x000D_
Description (French)
Influx développera cinq nouveaux rapports structurés, qui permettront à Influx d’offrir ces solutions aux services hospitaliers que nous n’avons pas ciblés par le passé, à savoir Cardiac CT et Pediatrics. De plus, nos huit (anciens) rapports structurés existants seront testés et vérifiés avec un nouveau système PACS.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Scarborough North
Federal Riding (French)
Scarborough-Nord
Federal Riding Number
35096
NAICS Code
622310
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
840077309
Recipient City
Scarborough|Scarborough
Recipient Country
CA
Recipient Legal Name
Influx Inc. (ON)
Recipient Postal Code
M1B 5N1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q1-895974
